RGEN

#1072
Repligen Corp
131.0300 USD
+6.88%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
131.0300
131.0300
1年のレンジ
109.6600
175.5700
1日の変化
+6.88%
月次変化
+13.62%
6か月変化
-20.92%
1年の変化
-20.92%
以前の終値
122.5900
始値
131.0300
Bid
Ask
安値
131.0300
High
131.0300
ボリューム
71
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 7.3811 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
190.53
売上高対価格比率
0.01

Repligen Corporation

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

ニュース